Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_assertion type Assertion NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_head.
- NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_assertion description "[In contrast, A3669G GR carriers showed a significantly reduced prevalence of type 2 diabetes mellitus compared with wild type (19 vs 68%, P=0.001) despite the higher levels of both serum morning (21.7�6 vs 27.3�8.6??g/dl, P=0.009) and midnight cortisol (18.8�5.8 vs 24.0�8.0??g/dl, P=0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_provenance.
- NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_assertion evidence source_evidence_literature NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_provenance.
- NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_assertion SIO_000772 22048965 NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_provenance.
- NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_assertion wasDerivedFrom befree-20150227 NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_provenance.
- NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_assertion wasGeneratedBy ECO_0000203 NP434858.RAXFjyiIG0loptoJKy-2EXYESIFeCCLdYGsQyX1hDSiYI130_provenance.